Dr. Sarah Stacey

Sarah Stacey is a South African clinician-researcher in infectious diseases with a strong focus on HIV-associated complications and critical care. Her work spans hospital-based epidemiology, antimicrobial stewardship, and the management of severe opportunistic and nosocomial infections. She collaborates across tertiary academic hospitals and national surveillance platforms, contributing to research that informs practice in high HIV-burden settings.

Her publications highlight expertise in cryptococcal meningitis, demonstrating the survival benefits of flucytosine-containing regimens and the value of cryptococcal antigen screening programmes. She has also examined SARS-CoV-2 dynamics in immunocompromised people living with HIV, offering insights into viral shedding and transmission risk. These studies bridge clinical management with public health policy.

Additional work on Candida auris outbreaks, infection prevention, cervical cancer screening in women with HIV, and antibiotic stewardship in paediatric wards underscores a commitment to improving quality of care. Across her research, Stacey integrates clinical insight with laboratory and epidemiological methods, advancing evidence-based strategies to reduce mortality from infectious diseases in resource-limited contexts.